Levetiracetam Stada

Levetiracetam, the active ingredient in Levetiracetam Stada, is a Antiepileptic presented as an oral tablet for Oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to control seizure activity. - Partial seizures: reduces seizure frequency in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps achieve seizure control in primary generalized epilepsy. - Myoclonic seizures: diminishes myoclonic jerks in appropriate seizure syndromes.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Somnolence: increased sleepiness during the day. - Irritability: mood changes or heightened agitation. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare but life‑threatening skin disorder. - Suicidal thoughts: emergence of depressive ideation. - Blood dyscrasias: abnormal blood counts such as neutropenia. - Multi‑organ hypersensitivity: systemic reaction affecting liver, kidneys, or lungs. - Severe skin rash: extensive erythema or blistering.

Before initiating therapy, clinicians should assess individual risk factors and monitor patients regularly. - Renal impairment: adjust dose according to renal function. - Hepatic dysfunction: use with caution; monitor liver enzymes. - Psychiatric history: observe for mood changes or suicidal ideation. - Concomitant CNS depressants: may enhance sedation; dose adjustments may be needed. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levetiracetam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: enzyme‑inducing agents that may lower levetiracetam plasma levels. - Alcohol: can increase central nervous system depression.

Moderate Interactions (Monitor Closely): - Benzodiazepines or opioids: may enhance sedative effects. - Probenecid or other renal excretion inhibitors: may raise levetiracetam concentrations. - Live vaccines: potential reduction in vaccine efficacy. - Other antiepileptic drugs: may require dose titration based on clinical response.